e-mailprint

Terumo Interventional Systems Launches a Complete Line of Coronary Diagnostic Catheters; Featuring two exclusive tip shapes for transradial access

[Note: Terumo Interventional Systems is another Terumo business dedicated to the treatment of cardiac and vascular disease.]

SOMERSET, N.J. — Dec. 1, 2008 — The Tiger and Jacky tip shapes stand out in Terumo's newest family of products.

Terumo Interventional Systems announces the launch of OptitorqueTM, its new line of coronary diagnostic catheters, featuring the exclusive Tiger and Jacky tip shapes designed and cleared specifically for transradial procedures.

"The Optitorque catheters, specially designed for radial approach, will help to generalize the radial technique by reducing the learning curve," said Dr. Ramon Quesada, Medical Director of Interventional Cardiology at Miami Baptist Cardiac & Vascular Institute.

With a simple clockwise or counter clockwise rotation, the Tiger and Jacky tip shapes enable angiography of both the RCA and LCA with one catheter. This eliminates the catheter exchange step and can potentially shorten procedure and fluoroscopic time.

"These Optitorque catheters are valuable tools for the transradial approach. They can be used for left coronary artery, right coronary artery and LV. So, the need for the exchange of catheters is greatly reduced ... They are great tools and make radial cardiac catheterization easier," said Tak Kwan, MD, FACC Associate Clinical Professor of Medicine, Senior Associate Director of Cardiac Catheterization Laboratory and Interventional Cardiology Beth Israel Medical Center.

"The Tiger and Jacky tip shapes are paramount to the Optitorque product line. The Optitorque family offers optimum torque control and precise placement, which contribute to catheterization success," said Gary Clifton, Marketing Manager for Terumo Interventional System's coronary product line. "It is the coronary diagnostic catheter to use when performance matters."

With its double-braided stainless steel mesh middle layer for superior (1:1) torque control and its large lumen for high flow of contrast, the Optitorque's construction is the key to its performance.

For more information, customers can contact Terumo Interventional Systems by calling its Inside Sales Customer Care Team at 800-862-4143 or by visiting www.terumois.com.

Terumo Interventional Systems Terumo Interventional Systems (TIS), a strategic business unit of Terumo Medical Corporation, directly markets a full line of guidewires, catheters, introducer sheaths, guiding sheaths and embolization products for use in a multitude of different interventional procedures.

Interventional Radiologists, Interventional Neuroradiologists, Interventional Cardiologists and Vascular Surgeons are among the medical professionals who depend upon TIS products to access and cross difficult-to-reach lesions thereby allowing therapeutic intervention in previously unreachable vascular beds.

Terumo Medical Corporation Founded in 1972 as a Terumo Corporation subsidiary, Terumo Medical Corporation (TMC) develops, manufactures and markets high-quality medical devices used in a broad range of applications in numerous healthcare markets. TMC manufactures a broad portfolio of entry-site management products, IV catheters and syringes, and a line of sterile connection devices used in hospitals and blood banks worldwide.

Terumo Corporation Tokyo-based Terumo Corporation is one of the world's leading medical device manufacturers with $3.0 billion in sales and operations in more than 160 nations. Founded in 1921, the company develops, manufactures and distributes world-class medical devices including products for use in cardiothoracic surgery, interventional procedures, and transfusion medicine; the company also manufactures a broad array of syringe and hypodermic needle products for hospital and physician office use. Terumo contributes to society by providing valued products and services to the healthcare market and by responding to the needs of healthcare providers and the people they serve. Terumo Corporation's shares are listed on the first section of the Tokyo Stock Exchange (No. 4543, Reuters symbol <4543.T>, or Bloomberg 4543:JP) and is a component of the Nikkei 225, Japan's leading stock index.